MAAT INDEX

CLAIM #23006 · EMR (EMR) · 2026Q1 earnings call · Feb 3, 2026 · due Sep 30, 2026

Yes. I mean so if you looked at the phasing of the back backlog, they're very supportive of hitting our second half sales.

Ram Krishnan · COO

PENDING
graded after results covering Sep 30, 2026 are reported

How to check this claim

Look at: Second-half fiscal year net sales growth (year-over-year)

It came true if: Second-half sales growth in mid-single-digit percent range (approximately 4%-6%)

Where: Company income statement / quarterly earnings release (Q3 and Q4 FY2026 results)

In context

sure that we're addressing this with our suppliers and ensuring that we have enough availability to cover the year and beyond. Nigel Coe: That's great color. Thanks, guys. Ram Krishnan: Thank you. Operator: Our next question comes from the line of Steve Tusa with JPMorgan. Please proceed with your question. Shigusa Kotoko: Hi, this is Shigusa Kotoko on for Steve. Thanks for taking my question. Just following up on the orders, the order trends are encouraging and the backlog is up quarter over quarter too. But just there's longer cycle orders in there too, as you mentioned, earlier. And so just how should we think about the cadence of these orders translating into sales? And what businesses specifically do as expect to hit the second half that supports the full year guidance? Ram Krishnan: Yes. I mean so if you looked at the phasing of the back backlog, they're very supportive of hitting our second half sales. So these backlogs translate into the mid single digit growth, tell the percent growth that we've guided for the second half. Our trailing twelve month orders at 6% also substantiate that. Our backlog at $7.9 billion which is up 9% also phase into the second half and into the 2027. The backlog build is frankly across the board, certainly in our control systems and software business, both in power as well as our Delta V business. In Final Control, we have a balanced backlog position in our sensor business to support the second half. So the build is across the board. Operator: Thank you. Our next question comes from the line of Jeff Sprague with Vertical Research Partners. Please proceed with your question. Jeff Sprague: Thanks. Good afternoon, everyone. Well, congrats five years. Can't beli

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2026Q1 earnings call.